Efficacy and Tolerability Outcomes of Treatment for Idiopathic Pulmonary Fibrosis. Real-life Experience. Respirar, [S. l.], v. 15, n. 3, 2023. DOI: 10.55720/respirar.15.3.2. Disponível em: https://respirar.alatorax.org/index.php/respirar/article/view/147. Acesso em: 28 jul. 2026.